ru-66647 and Myasthenia-Gravis

ru-66647 has been researched along with Myasthenia-Gravis* in 3 studies

3 other study(ies) available for ru-66647 and Myasthenia-Gravis

Article	Year
Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment. Neurology, 2006, Dec-26, Volume: 67, Issue:12 Telithromycin, a new ketolide antibiotic, has been implicated in the exacerbation or unmasking of myasthenia gravis. This retrospective study presents two clinical reports and summarizes eight other suspected cases notified to the French pharmacovigilance system, highlighting a potentially life-threatening risk of telithromycin treatment in myasthenic patients. An important common feature was that, in seven cases, symptomatology occurred within 2 hours of first telithromycin intake--notably in cases of severe exacerbation. Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Ketolides; Male; Middle Aged; Myasthenia Gravis	2006
Telithromycin and myasthenic crisis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-15, Volume: 43, Issue:12 Topics: Anti-Bacterial Agents; Female; Humans; Ketolides; Middle Aged; Myasthenia Gravis	2006
Telithromycin and myasthenia gravis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Dec-01, Volume: 37, Issue:11 Topics: Drug Approval; Drug Monitoring; Humans; Ketolides; Macrolides; Myasthenia Gravis	2003